Presented by:
L. Stewart Massad, MD
Monday, September 23, 2013 at 2:00PM – 3:30PM EST
Participants:
URL: https://www.mymeetings.com/nc/join/
Conference number: PW7314711
Audience passcode: 3356687
Participants can join the event directly at:
https://www.mymeetings.com/nc/join.php?i=PW7314711&p=3356687&t=c
Women with HIV are at increased risk for cervical cancer and cervical precancerous disease. Understanding the impact of HIV on cervical cancer and HPV infection is important for appropriate screening and management of these women. This presentation will provide the following objectives:
• To understand the impact of impaired cell mediated immunity on the natural history HPV in women with HIV
• To understand the epidemiology and management of intraepithelial neoplasia in women with HIV
• To follow women with HIV and abnormal Paps/CIN in a way that minimizes both cervical cancer risk and burden of care
Dr. Massad is a professor in the Division of Gynecologic Oncology at the Washington University School of Medicine in St. Louis. His career has focused on cervical cancer prevention, and he has also worked on assessing relationships between HIV-induced immunosuppression and cervical cancer and cancer precursors. Dr. Massad received his medical degree from Duke University in Durham, North Carolina where he also completed his residency in obstetrics and gynecology. He trained in internal medicine at Albany Medical Center in Albany, New York and completed a fellowship in gynecologic oncology at the Washington University School of Medicine in St. Louis. Dr. Massad earned his Bachelor of Arts at Williams College in Williamstown, Massachusetts.
POC: Teri Larkins TLarkins@cdc.gov or Jacqueline Miller JMiller5@cdc.gov
*Participants have the opportunity to send questions for Dr. Massad prior to the webinar. Please send questions to tlarkins@cdc.gov by September 19, 2013 5pm EST. Subject Line: “CxCa HIV Screening Massad Webinar Questions”
No comments:
Post a Comment